Supplemental material
OncoImmunology
Volume 5, 2016 - Issue 6
Open access
2,889
Views
29
CrossRef citations to date
0
Altmetric
Original Research
Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
Ming ChengDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
, Brian H. SantichDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
, Hong XuDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
, Mahiuddin AhmedDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
, Morgan HuseImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
& Nai-Kong V. CheungDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence[email protected]
Article: e1168557
|
Received 18 Feb 2016, Accepted 14 Mar 2016, Published online: 15 Jun 2016
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.